Industry Trends Oxygen therapy devices, sleep diagnostic devices and respiratory disposables, are expected to be the fastest-growing segments in the European anesthesia, respiratory and sleep management device market. As an alternative to the centralized delivery of concentrated oxygen, devices that allow patients to generate their own oxygen at home have played a significant role. This
In addition to generating unit sales growth, advancements in technology are set to shift preferences away from oxygen cylinders and bulky stationary equipment, towards portable devices. While transfilling devices and concentrators are similar in terms of ASP, cylinders, regulators and conserver components are less expensive, which might force the overall ASP of the market down.
The full report suite on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices includes anesthesia delivery units (ADU), anesthesia monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.
In 2021, the Europe anesthesia, respiratory and sleep therapy devices market size is estimated to reach €1.8 billion, with the Sleep Diagnostic Device market expected to experience the fastest growth. In spite of COVID19, the EU market size is projected to increase over the forecast period to exceed $1.8 billion in 2027. Currently, over 35%
This report analyzes the market for the following products: anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices and sleep diagnostic devices. The sleep therapy device market is the largest of the markets covered in this report, largely owing to the increasing awareness of sleep apnea, its risks and its co-morbidities.
Oxygen therapy patients require a number of devices in the long term to treat their condition. Overall, the oxygen therapy market is broken down into six types of devices: concentrators, liquid oxygen, conservers, regulators, transfilling devices and aluminum medical oxygen cylinders. Concentrators and oxygen cylinders are the two main devices that deliver oxygen to patients while transfilling devices, regulators and conservers are used alongside a cylinder as a secondary component.
Among Western European countries, France has the largest number of patients on long-term oxygen therapy, and the extensive use of oxygen concentrators is encouraged by some of the highest reimbursement rates in Europe. In contrast, the market for alternative oxygen therapy devices in Italy is well below what population levels, or the number of COPD patients, would suggest. This is largely due to the fact that the reimbursement and regulatory system in Italy is heavily weighted toward the use of liquid oxygen.